VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EDAPEdap Tms S.a.
$4.75$178M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksEDAPCash Flow

Edap Tms S.a. (EDAP) Cash Flow Statement

29Y historyFree accessUpdated daily

Cash burn remains a critical concern, as evidenced by free cash flow margins reaching -49.0% in 2025Q1 and a cash position that has depleted from $43.5M in 2023Q4 to $15.0M in 2026Q1.

EDAP Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97
Cash from Operations-14.08M-16.41M-13.58M-14.68M-3.02M4.45M2.25M3.8M175K-3.06M1.12M1.34M-1.01M-2.5M-162K-737K-3.82M-3.66M-4.59M-2.73M-1.9M-284.53K-1.13M-3.64M-7.97M-3.41M29.81K-2.54M-6.39M-363.64K
Operating CF Margin %--23.19%-21.19%-24.29%-5.49%10.09%5.41%8.46%0.45%-8.56%3.14%4.15%-3.79%-10.36%-0.62%-3.31%-16.1%-14.72%-19.92%-12.22%-9.38%-1.37%-5.11%-19.76%-39.89%-14.19%0.11%-13.23%-27.57%-1.11%
Operating CF Growth %85.37%-20.8%7.45%-385.38%-168.03%97.23%-40.69%2071.43%105.72%-373.37%-16.37%231.95%59.36%-1440.12%78.02%80.7%-4.2%20.23%-68.05%-43.77%-568.13%74.87%68.92%54.28%-133.92%-11526.85%101.18%60.36%-1658.61%-
Net Income-30.02M-29.25M-19.02M-21.18M-2.93M700K-1.94M1.51M-338K-681K3.84M-1.67M-512K-5.02M-7.47M-938K-12.72M-7.77M1.6M-5.44M-3.43M-1.06M-1.15M-8.96M-4.04M7.15M11.74M-6.25M-7.16M181.82K
Depreciation & Amortization03.41M2.56M1.91M1.6M1.92M2.52M1.88M1.61M1.57M1.02M1M900K1.18M931K1.41M1.23M1.8M1.78M1.3M1.26M1.2M1.05M981.42K1.12M1.1M1.35M1.8M1.53M1.45M
Stock-Based Compensation02.56M3.28M6.87M2.1M1.9M0260K289K382K360K66K140K367K243K000000000000000
Deferred Taxes0-231K-97K42K48K-563K51.3K-106K-153K-153K65K23K-18K-65K-52K293K180K-57K-77K-161.18K-90.92K83.59K254.5K-225.5K5.72K131.5K72.4K-207.7K85.27K-90.91K
Other Non-Cash Items-20.04M4.17M1.65M583K469K-33K1.75M247K39K-2.49M-3.89M1.97M-1.45M294K4.31M-1.63M6.71M3.21M-5.3M1.59M534.17K358.83K-1.32M-193.74K953-13.28M-2.13K994-85.27K636.36K
Working Capital Changes4.38M2.93M-1.96M-2.9M-4.32M521K-124.26K8K-1.27M-1.69M-287K-56K-75K751K1.88M-683K700K-971K-2.85M-425.93K-415.21K-1.04M28.77K4.76M-3.05M1.49M2.17M2.22M85.27K-2.55M
Change in Receivables0-567K-139K-4.91M-1.94M-103K1.3M908K-1.01M-1.64M1.8M-1.79M1.2M2.55M2.51M000000000000000
Change in Inventory06.85M-4.04M-4.21M-4.48M166K-631.54K-1.04M-704K669K-1.99M-381K-1.26M-961K-497K-436K-355K-319K-126K-820.99K428.85K-680.51K2.34M1.11M-428.84K559.71K3.29M24.84K-1.02M818.18K
Change in Payables00001.12M0-481.07K-249K-70K426K-153K518K26K-822K-91K508K00000000000000
Cash from Investing-5.18M-5.71M-4.12M-4.34M-2.38M-1.64M-2.29M-1.53M-1.57M-2.03M-384K-541K-1.03M-589K234K-613K-685K402K-712K-1.24M-1.63M-1.06M16.23K-540.73K5.09M23.67M2.07M-1.77M-255.8K-6.45M
Capital Expenditures-4.54M-1.21M-1.31M-1.18M-2.18M-393K-722.74K-396K-1.87M-2.07M-1.33M-650K-1.02M-760K-650K-870K-609K-738K-1.12M-559.67K-250.79K-395.98K-247.12K-399.4K-859.58K-848.55K-456.77K-498.88K-682.13K-5.82M
CapEx % of Revenue6.3%1.71%2.05%1.95%3.96%0.89%1.73%0.88%4.77%5.8%3.72%2.02%3.81%3.16%2.49%3.9%2.57%2.97%4.85%2.5%1.24%1.9%1.12%2.17%4.3%3.53%1.67%2.6%2.94%17.78%
Acquisitions00000000370.49K79.84K0123.52K0000000000-17.7K-27K-210.61K00000
Investments------------------------------
Other Investing-644.05K-4.5M-2.81M-3.17M-195K-1.26M-1.57M-1.12M300K40K-58K109K-13K135K348K257K330K1.15M1.1M-587.79K-347.02K-661.94K281.06K-428.78K619.43K2.87M2.53M-1.27M-2.9M-636.36K
Cash from Financing8.51M8.61M4.63M-911K21.74M20.27M3.65M-664K1.18M2.87M7.69M1.99M6.04M1.94M1.34M-327K652K992K296K11.84M5.19M187.44K-82.62K-667.78K-256.35K-4.14M-1.81M-1.76M3.67M14.64M
Debt Issued (Net)08.61M4.52M-1.17M-867K-1.47M3.58M-974K1.18M2.21M1.4M893K-98K-3.85M-555K-1.08M-8.31M-2.55M-304K11.47M-53.04K188.28K-82.62K-667.78K-256.35K-4.06M-1.97M-1.71M5.97M15.09M
Equity Issued (Net)000021.96M21.29M68.4K00548K6.2M1.09M6.22M5.67M1.9M758K8.97M2.62M600K352K00000-74.18K159.71K-48.7K-2.3M0
Dividends Paid000000000000000000000000000000
Share Repurchases0000000000000000000000000-74.18K0-48.7K-2.3M0
Other Financing8.51M0115K261K648K443K0310K1K115K0128K-82K113K-1K-1K-1K922K01K5.24M-8450000000-454.55K
Net Change in Cash15.01M-10.54M-13.63M-19.66M15.95M22.49M6.77M1.42M-540K-1.99M8.41M2.44M4.46M-360K2.14M-2.47M-4.22M-2.24M-3.7M7.64M1.58M-1.08M-1.03M-5.32M-3.61M16M127.77K-5.55M-3.07M14.64M
Free Cash Flow-19.27M-22.17M-17.68M-18.97M-5.21M2.8M1.65M2.35M-1.69M-5.13M-207K688K-2.04M-3.25M-812K-1.61M-4.43M-4.4M-5.71M-3.29M-2.15M-680.51K-1.38M-4.04M-8.83M-4.26M-426.96K-3.03M-7.08M-6.18M
FCF Margin %-26.77%-31.34%-27.58%-31.4%-9.45%6.35%3.96%5.23%-4.32%-14.35%-0.58%2.13%-7.6%-13.52%-3.12%-7.21%-18.67%-17.69%-24.77%-14.73%-10.62%-3.27%-6.23%-21.92%-44.19%-17.72%-1.56%-15.83%-30.51%-18.89%
FCF Growth %0.77%-25.35%6.79%-264.39%-286.03%69.8%-29.83%238.67%66.98%-2378.74%-130.09%133.81%37.48%-300.86%49.47%63.7%-0.57%22.91%-73.41%-53.03%-216.21%50.67%65.88%54.21%-107.47%-896.61%85.93%57.13%-14.48%-
FCF per Share-0.51-0.59-0.47-0.51-0.150.090.060.08-0.06-0.18-0.010.03-0.09-0.16-0.05-0.12-0.34-0.42-0.59-0.36-0.23-0.08-0.17-0.52-1.13-0.54-0.05-0.39-0.85-0.93
FCF Conversion (FCF/Net Income)0.64x0.56x0.71x0.69x1.03x6.35x-1.32x2.51x-0.52x4.49x0.29x-0.80x1.98x0.50x0.02x0.79x0.30x0.47x-2.88x0.50x0.55x0.27x0.99x0.41x1.97x-0.48x0.00x0.41x0.89x-2.00x
Interest Paid000000000000000000000000000000
Taxes Paid000000000000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetAdequate
Cash FlowBurning
Top Statement Risk

High cash burn rate

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Persistent Disconnect Between Earnings Reality

As reported in recent financial filings, EDAP's operating cash flow consistently trails net losses, with an OCF/NI ratio that frequently fluctuates below 1.0, indicating that the company's reported net income is not being supported by actual cash generation from its core medical device operations.

The recurring gap between net income and operating cash flow suggests that the company's accounting earnings are significantly impacted by non-cash items or timing differences that do not translate into liquidity. Investors should monitor whether this conversion ratio improves as the company attempts to scale its US installed base, as current trends imply a reliance on external financing to bridge the gap.

Negative Free Cash Flow Trajectory

Based on quarterly data, EDAP's free cash flow margins remain deeply negative, reaching as low as -49.0% in 2025Q1, which underscores the significant capital intensity required to sustain the company's current market expansion strategy without achieving self-sustaining profitability in the near term.

The consistent negative FCF trajectory reflects a business model that is currently consuming cash to fund growth rather than generating it. This trend warrants further investigation into whether the company can reach a cash-flow-positive state before its existing liquidity reserves are exhausted by ongoing operational requirements.

Capital Intensity Amidst Growth Phase

According to recent SEC filings, EDAP's capital expenditure as a percentage of revenue has fluctuated between 4.2% and 10.0%, highlighting the ongoing investment required to maintain and expand the Focal One platform's footprint in competitive medical device markets.

The variability in capital intensity suggests that management is balancing the need for infrastructure investment with the reality of limited cash resources. The current level of spending appears necessary to support the technical requirements of the HIFU segment, though it continues to exert downward pressure on the company's overall cash position.

Volatile Working Capital Management Trends

As indicated by quarterly cash flow statements, working capital changes have been highly inconsistent, swinging from a $2.8M inflow in 2026Q1 to a $2.2M outflow in 2023Q4, which suggests significant volatility in the company's ability to manage its receivables and inventory cycles effectively.

This instability in working capital management may reflect the lumpy nature of high-value medical equipment sales and the challenges of managing a hybrid distribution and direct-sales model. Such fluctuations complicate cash flow forecasting and suggest that the company's operational efficiency remains sensitive to the timing of large-scale customer payments.

EDAP — Frequently Asked Questions

Quick answers to the most common questions about buying EDAP stock.

How much cash does Edap Tms S.a. (EDAP) generate from operations?

Edap Tms S.a. (EDAP) generated $-16.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Edap Tms S.a.'s free cash flow?

Edap Tms S.a. (EDAP) reported negative free cash flow of $22.2M in 2025, indicating capital requirements exceeded cash from operations.

What is Edap Tms S.a.'s capital expenditure (CapEx)?

Edap Tms S.a. (EDAP) spent $1.2M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.